EE05507B1 - Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks - Google Patents

Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks

Info

Publication number
EE05507B1
EE05507B1 EEP200300239A EEP200300239A EE05507B1 EE 05507 B1 EE05507 B1 EE 05507B1 EE P200300239 A EEP200300239 A EE P200300239A EE P200300239 A EEP200300239 A EE P200300239A EE 05507 B1 EE05507 B1 EE 05507B1
Authority
EE
Estonia
Prior art keywords
percolesterolemia
heterosgococcal
rosuvastatin
family
treatment
Prior art date
Application number
EEP200300239A
Other languages
English (en)
Estonian (et)
Inventor
Ali@Raza
Howard@Gerard@Hutchinson
Original Assignee
AstraZeneca@AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05507(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca@AB filed Critical AstraZeneca@AB
Publication of EE200300239A publication Critical patent/EE200300239A/xx
Publication of EE05507B1 publication Critical patent/EE05507B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300239A 2000-11-22 2001-11-16 Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks EE05507B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0028429.9A GB0028429D0 (en) 2000-11-22 2000-11-22 Therapy
PCT/GB2001/005041 WO2002041895A1 (en) 2000-11-22 2001-11-16 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Publications (2)

Publication Number Publication Date
EE200300239A EE200300239A (et) 2003-08-15
EE05507B1 true EE05507B1 (et) 2012-02-15

Family

ID=9903629

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300239A EE05507B1 (et) 2000-11-22 2001-11-16 Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks

Country Status (35)

Country Link
US (1) US6858618B2 (no)
EP (1) EP1339409B1 (no)
JP (2) JP5062940B2 (no)
KR (1) KR100815042B1 (no)
CN (1) CN1268339C (no)
AR (1) AR031766A1 (no)
AT (1) ATE394103T1 (no)
AU (2) AU2002214165B9 (no)
BG (1) BG66009B1 (no)
BR (1) BR0115511A (no)
CA (1) CA2429263C (no)
CY (1) CY1110428T1 (no)
CZ (1) CZ301583B6 (no)
DE (1) DE60133921D1 (no)
DK (1) DK1339409T3 (no)
EE (1) EE05507B1 (no)
ES (1) ES2305118T3 (no)
GB (1) GB0028429D0 (no)
HK (1) HK1056691A1 (no)
HU (1) HUP0301380A3 (no)
IL (2) IL155919A0 (no)
IS (1) IS6819A (no)
MX (1) MXPA03004336A (no)
MY (1) MY134902A (no)
NO (1) NO326245B1 (no)
NZ (1) NZ525754A (no)
PL (1) PL365386A1 (no)
PT (1) PT1339409E (no)
RU (1) RU2294744C2 (no)
SI (1) SI1339409T1 (no)
SK (1) SK6212003A3 (no)
TW (1) TWI238720B (no)
UA (1) UA75614C2 (no)
WO (1) WO2002041895A1 (no)
ZA (1) ZA200303636B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
US7407965B2 (en) * 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7452901B2 (en) * 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US20090247488A1 (en) * 2003-04-25 2009-10-01 Carina Cannizzaro Anti-inflammatory phosphonate compounds
US7470724B2 (en) * 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US20050261237A1 (en) * 2003-04-25 2005-11-24 Boojamra Constantine G Nucleoside phosphonate analogs
US7417055B2 (en) * 2003-04-25 2008-08-26 Gilead Sciences, Inc. Kinase inhibitory phosphonate analogs
MXPA05011297A (es) * 2003-04-25 2006-05-25 Gilead Sciences Inc Analogos antivirales de fosfonato.
US7396927B2 (en) * 2003-08-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
US7432273B2 (en) * 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
TW200526596A (en) 2003-11-24 2005-08-16 Teva Pharma Crystalline ammonium salts of rosuvastatin
EP1689723B1 (en) * 2003-12-02 2011-04-27 Teva Pharmaceutical Industries, Ltd. Reference standard for characterization of rosuvastatin
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
AU2005247160A1 (en) * 2004-05-26 2005-12-08 Kgk Synergize Inc Functional foods comprising flavonoids and tocotrienols and methods thereof
US7179916B2 (en) * 2004-07-13 2007-02-20 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin
UA88313C2 (ru) 2004-07-27 2009-10-12 Гилиад Сайенсиз, Инк. Фосфонатные аналоги соединений ингибиторов вич
EP1851206B1 (en) * 2005-02-22 2012-08-15 Teva Pharmaceutical Industries, Ltd. Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
KR20070062996A (ko) * 2005-08-16 2007-06-18 테바 파마슈티컬 인더스트리즈 리미티드 결정성 로수바스타틴 중간체
US9427437B2 (en) 2008-01-31 2016-08-30 The Trustees Of The University Of Pennsylvania Hypercholesterolemia and tendinous injuries
US8383614B2 (en) * 2008-01-31 2013-02-26 The Trustees Of The University Of Pennsylvania Hypercholestrolemia and tendinous injuries
WO2009143776A1 (zh) 2008-05-27 2009-12-03 常州制药厂有限公司 瑞舒伐他汀钙盐的制备方法及其中间体
CN102089318B (zh) 2008-07-08 2014-05-21 吉里德科学公司 Hiv抑制剂化合物的盐
TWI804870B (zh) 2012-09-17 2023-06-11 美商瑪德瑞高製藥公司 用以合成甲狀腺激素類似物及其多形體之方法
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10600502B2 (en) 2016-12-20 2020-03-24 Astrazeneca Uk Ltd. Systems and methods for dispensing a statin medication over the counter
SI3661937T1 (sl) 2017-08-01 2021-11-30 Gilead Sciences, Inc. Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
WO2020243134A1 (en) 2019-05-27 2020-12-03 Immatics US, Inc. Viral vectors and their use in adoptive cellular therapy
DE102020111571A1 (de) 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220008519A1 (en) 2020-07-09 2022-01-13 Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS) Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho
US20220056411A1 (en) 2020-08-21 2022-02-24 Immatics US, Inc. Methods for isolating cd8+ selected t cells
CN116847847A (zh) * 2021-02-01 2023-10-03 马德里加尔制药公司 用于治疗肝紊乱或血脂紊乱的瑞舒伐他汀和resmetirom的治疗组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
AU2001262945B2 (en) * 2000-09-20 2006-02-02 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate

Also Published As

Publication number Publication date
BG107811A (bg) 2004-03-31
PT1339409E (pt) 2008-07-07
MY134902A (en) 2007-12-31
US6858618B2 (en) 2005-02-22
NO20032292D0 (no) 2003-05-21
TWI238720B (en) 2005-09-01
AU1416502A (en) 2002-06-03
CZ20031406A3 (cs) 2003-09-17
CA2429263A1 (en) 2002-05-30
JP2010031047A (ja) 2010-02-12
IS6819A (is) 2003-05-19
CY1110428T1 (el) 2015-04-29
GB0028429D0 (en) 2001-01-10
US20040072852A1 (en) 2004-04-15
RU2294744C2 (ru) 2007-03-10
AU2002214165B9 (en) 2013-07-04
HUP0301380A2 (hu) 2003-10-28
SK6212003A3 (en) 2003-11-04
JP2004522714A (ja) 2004-07-29
NZ525754A (en) 2004-10-29
SI1339409T1 (sl) 2008-08-31
IL155919A0 (en) 2003-12-23
DE60133921D1 (de) 2008-06-19
BR0115511A (pt) 2003-12-30
EP1339409A1 (en) 2003-09-03
EE200300239A (et) 2003-08-15
NO326245B1 (no) 2008-10-27
ZA200303636B (en) 2004-08-12
ATE394103T1 (de) 2008-05-15
DK1339409T3 (da) 2008-09-08
KR100815042B1 (ko) 2008-03-18
HUP0301380A3 (en) 2007-03-28
BG66009B1 (bg) 2010-10-29
NO20032292L (no) 2003-07-17
AU2002214165B2 (en) 2006-12-14
CA2429263C (en) 2009-03-17
PL365386A1 (en) 2005-01-10
CN1630520A (zh) 2005-06-22
EP1339409B1 (en) 2008-05-07
CN1268339C (zh) 2006-08-09
ES2305118T3 (es) 2008-11-01
CZ301583B6 (cs) 2010-04-21
HK1056691A1 (en) 2004-02-27
UA75614C2 (uk) 2006-05-15
WO2002041895A1 (en) 2002-05-30
MXPA03004336A (es) 2003-08-19
AR031766A1 (es) 2003-10-01
IL155919A (en) 2009-09-01
KR20030048479A (ko) 2003-06-19
JP5062940B2 (ja) 2012-10-31

Similar Documents

Publication Publication Date Title
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
ID30590A (id) Celana sekali pakai jenis-celana pendek
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
DK1604680T3 (da) Anvendelse af butulinumtoksin ved behandlingen af neuralgisk smerte
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE50112013D1 (de) Deodorantien und antiperspirantien
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
NO20032122D0 (no) Forbedret behandling
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DE60223576D1 (de) Hautbehandlungszusammensetzung
NO20041968L (no) Anvendelse av cystationin
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
ID30381A (id) Penggunaan arilalkanoilpiridazina
ITMI20011820A0 (it) Trattamento di ustioni

Legal Events

Date Code Title Description
HD1A Correction of address
MM4A Lapsed by not paying the annual fees

Effective date: 20161116